vs
Side-by-side financial comparison of Bolt Biotherapeutics, Inc. (BOLT) and Worksport Ltd (WKSP). Click either name above to swap in a different company.
Worksport Ltd is the larger business by last-quarter revenue ($4.7M vs $2.5M, roughly 1.9× Bolt Biotherapeutics, Inc.). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs -31.2%).
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
Worksport LtdWKSPEarnings & Financial Report
Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.
BOLT vs WKSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5M | $4.7M |
| Net Profit | $-6.6M | — |
| Gross Margin | — | 30.1% |
| Operating Margin | -283.4% | -129.6% |
| Net Margin | -265.2% | — |
| Revenue YoY | — | 62.0% |
| Net Profit YoY | 58.4% | — |
| EPS (diluted) | $-9.38 | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5M | $4.7M | ||
| Q3 25 | $2.2M | $5.0M | ||
| Q2 25 | $1.8M | $4.1M | ||
| Q1 25 | $1.2M | $2.2M | ||
| Q4 24 | $0 | $2.9M | ||
| Q3 24 | $1.1M | $3.1M | ||
| Q2 24 | $1.3M | $1.9M | ||
| Q1 24 | $5.3M | $512.6K |
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-7.1M | $-4.9M | ||
| Q2 25 | $-8.6M | $-3.7M | ||
| Q1 25 | $-11.0M | $-4.5M | ||
| Q4 24 | $-15.9M | — | ||
| Q3 24 | $-15.2M | $-4.1M | ||
| Q2 24 | $-21.2M | $-4.0M | ||
| Q1 24 | $-10.8M | $-3.7M |
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 31.3% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | — | 11.1% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -283.4% | -129.6% | ||
| Q3 25 | -355.1% | -95.6% | ||
| Q2 25 | -510.5% | -88.1% | ||
| Q1 25 | -991.4% | -190.0% | ||
| Q4 24 | — | -137.0% | ||
| Q3 24 | -1441.1% | -125.1% | ||
| Q2 24 | -1772.3% | -203.5% | ||
| Q1 24 | -324.1% | -709.9% |
| Q4 25 | -265.2% | — | ||
| Q3 25 | -329.4% | -98.3% | ||
| Q2 25 | -474.6% | -91.0% | ||
| Q1 25 | -903.4% | -199.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1330.1% | -132.4% | ||
| Q2 24 | -1662.4% | -208.9% | ||
| Q1 24 | -205.0% | -724.6% |
| Q4 25 | $-9.38 | $-0.65 | ||
| Q3 25 | $-3.72 | $-0.75 | ||
| Q2 25 | $-4.46 | $-0.71 | ||
| Q1 25 | $-0.29 | $-1.05 | ||
| Q4 24 | $-13.73 | $-1.14 | ||
| Q3 24 | $-7.93 | $-1.40 | ||
| Q2 24 | $-11.12 | $-1.55 | ||
| Q1 24 | $-0.28 | $-1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.5M | $5.9M |
| Total DebtLower is stronger | — | $2.7M |
| Stockholders' EquityBook value | $26.5M | $22.9M |
| Total Assets | $56.7M | $30.7M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.5M | $5.9M | ||
| Q3 25 | $31.9M | $3.8M | ||
| Q2 25 | $34.8M | $1.4M | ||
| Q1 25 | $38.8M | $5.1M | ||
| Q4 24 | $47.3M | $4.9M | ||
| Q3 24 | $53.8M | $1.9M | ||
| Q2 24 | $73.7M | $3.4M | ||
| Q1 24 | $91.3M | $3.5M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $26.5M | $22.9M | ||
| Q3 25 | $32.1M | $19.8M | ||
| Q2 25 | $38.8M | $17.3M | ||
| Q1 25 | $46.8M | $20.1M | ||
| Q4 24 | $57.2M | $17.4M | ||
| Q3 24 | $72.0M | $16.4M | ||
| Q2 24 | $85.9M | $19.1M | ||
| Q1 24 | $104.2M | $18.9M |
| Q4 25 | $56.7M | $30.7M | ||
| Q3 25 | $65.1M | $27.0M | ||
| Q2 25 | $75.5M | $23.6M | ||
| Q1 25 | $85.9M | $26.7M | ||
| Q4 24 | $99.6M | $25.7M | ||
| Q3 24 | $109.3M | $24.9M | ||
| Q2 24 | $124.2M | $27.2M | ||
| Q1 24 | $142.9M | $27.3M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2M | $-6.1M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -132.4% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.2M | $-6.1M | ||
| Q3 25 | $-9.7M | $-4.3M | ||
| Q2 25 | $-9.6M | $-3.1M | ||
| Q1 25 | $-13.4M | $-3.8M | ||
| Q4 24 | $-14.4M | $-2.2M | ||
| Q3 24 | $-14.0M | $-1.5M | ||
| Q2 24 | $-16.1M | $-3.6M | ||
| Q1 24 | $-16.8M | $-2.8M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-3.2M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-14.0M | $-1.7M | ||
| Q2 24 | — | $-3.7M | ||
| Q1 24 | — | $-3.0M |
| Q4 25 | — | -132.4% | ||
| Q3 25 | — | -92.1% | ||
| Q2 25 | — | -77.1% | ||
| Q1 25 | — | -180.4% | ||
| Q4 24 | — | -75.4% | ||
| Q3 24 | -1227.6% | -54.5% | ||
| Q2 24 | — | -195.1% | ||
| Q1 24 | — | -586.7% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.3% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 3.6% | 5.3% | ||
| Q2 24 | 0.0% | 6.4% | ||
| Q1 24 | 0.0% | 41.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
